Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: Bioorg Med Chem Lett. 2011 Mar 21;21(10):2986–2990. doi: 10.1016/j.bmcl.2011.03.047

Table 5.

Antiviral Potencies in Cells Infected with HIV-1 Containing Wild-Type or Mutant Integrase Enzymes.a

No. CC50 (μM) EC50 (μM, WT) Mutantsb
G140S/Q148H Y143R N155H
1 N/A 0.004 ± 0.002 425 x 53 x 35 x
4b-1 291 ± 51 61 ± 9 2 x 4 x 3 x
a

Data was obtained as indicated in the Supporting Information.

b

Fold-loss of potency relative to virus containing wild-type (WT) enzyme.

HHS Vulnerability Disclosure